Researchers assessed the effectiveness of vaccine-conferred immune protection against novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, any-cause visits to hospitals and emergency departments (ED), and deaths in Indiana.
Researchers assessed the effectiveness of vaccine-conferred immune protection against novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, any-cause visits to hospitals and emergency departments (ED), and deaths in Indiana.
Comments